Cantor Fitzgerald Forecasts TG Therapeutics FY2026 Earnings
TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for TG Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal anticipates that the biopharmaceutical company will post earnings per share of $1.80 for the […]
TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for TG Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal anticipates that the biopharmaceutical company will post earnings per share of $1.80 for the […]
